Jill C. Milne - Mar 1, 2022 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
CEO and President, Director
Signature
/s/ Jill C. Milne
Stock symbol
ATXS
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 06:19 PM
Previous filing
Jun 2, 2021
Next filing
Jun 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (right to buy) Award $0 +195K $0.00 195K Mar 1, 2022 Common Stock 195K $6.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 1, 2022, and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 17, 2022 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.